Gold nanoparticles can spot biomarker for blood clots

04/12/2010 | MIT Technology Review

Scottish scientists have developed gold nanoparticles that enable them to measure concentrations of thrombin, a protein linked to blood clots, in blood specimens using laser light. They hope the technology leads to tests in which patients are implanted with nanosensors to help detect blood clots and other diseases.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park